Viral Vector Manufacturing CDMO Services Market Report – Research, Industry Analysis Reports and Market Demands

Global Viral Vector Manufacturing CDMO Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Viral Vector Manufacturing CDMO Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Viral Vector Manufacturing CDMO Services by Company Revenue
- 3.2.2 Top 3 Viral Vector Manufacturing CDMO Services Players Market Share in 2025
- 3.2.3 Top 6 Viral Vector Manufacturing CDMO Services Players Market Share in 2025
3.3 Viral Vector Manufacturing CDMO Services Market: Overall Company Footprint Analysis
- 3.3.1 Viral Vector Manufacturing CDMO Services Market: Region Footprint
- 3.3.2 Viral Vector Manufacturing CDMO Services Market: Company Product Type Footprint
- 3.3.3 Viral Vector Manufacturing CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Viral Vector Manufacturing CDMO Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Viral Vector Manufacturing CDMO Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Viral Vector Manufacturing CDMO Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Viral Vector Manufacturing CDMO Services Market Forecast by Application (2027-2032)

6 North America

6.1 North America Viral Vector Manufacturing CDMO Services Consumption Value by Type (2021-2032)
6.2 North America Viral Vector Manufacturing CDMO Services Market Size by Application (2021-2032)
6.3 North America Viral Vector Manufacturing CDMO Services Market Size by Country
- 6.3.1 North America Viral Vector Manufacturing CDMO Services Consumption Value by Country (2021-2032)
- 6.3.2 United States Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 6.3.3 Canada Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Viral Vector Manufacturing CDMO Services Consumption Value by Type (2021-2032)
7.2 Europe Viral Vector Manufacturing CDMO Services Consumption Value by Application (2021-2032)
7.3 Europe Viral Vector Manufacturing CDMO Services Market Size by Country
- 7.3.1 Europe Viral Vector Manufacturing CDMO Services Consumption Value by Country (2021-2032)
- 7.3.2 Germany Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 7.3.3 France Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 7.3.5 Russia Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 7.3.6 Italy Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Viral Vector Manufacturing CDMO Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Viral Vector Manufacturing CDMO Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region
- 8.3.1 Asia-Pacific Viral Vector Manufacturing CDMO Services Consumption Value by Region (2021-2032)
- 8.3.2 China Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 8.3.3 Japan Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 8.3.5 India Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 8.3.7 Australia Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)

9 South America

9.1 South America Viral Vector Manufacturing CDMO Services Consumption Value by Type (2021-2032)
9.2 South America Viral Vector Manufacturing CDMO Services Consumption Value by Application (2021-2032)
9.3 South America Viral Vector Manufacturing CDMO Services Market Size by Country
- 9.3.1 South America Viral Vector Manufacturing CDMO Services Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Viral Vector Manufacturing CDMO Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Viral Vector Manufacturing CDMO Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country
- 10.3.1 Middle East & Africa Viral Vector Manufacturing CDMO Services Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)
- 10.3.4 UAE Viral Vector Manufacturing CDMO Services Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Viral Vector Manufacturing CDMO Services Market Drivers
11.2 Viral Vector Manufacturing CDMO Services Market Restraints
11.3 Viral Vector Manufacturing CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Viral Vector Manufacturing CDMO Services Industry Chain
12.2 Viral Vector Manufacturing CDMO Services Upstream Analysis
12.3 Viral Vector Manufacturing CDMO Services Midstream Analysis
12.4 Viral Vector Manufacturing CDMO Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Viral Vector Manufacturing CDMO Services market size was valued at US$ 856 million in 2025 and is forecast to a readjusted size of US$ 3592 million by 2032 with a CAGR of 23.0% during review period.
Viral Vector Manufacturing CDMO Services refer to providing professional viral vector production and development services to biopharmaceutical companies. These viral vectors are usually used in gene therapy, vaccine development, cell therapy and other fields. CDMO organizations are responsible for the design and optimization of viral vectors to large-scale production in accordance with GMP standards, ensuring the safety and effectiveness of the products, while strictly controlling the quality of each production link. These services provide key technical support for biopharmaceutical companies to help accelerate the development and commercialization of their products.
The Viral Vector Manufacturing CDMO Services market has emerged as a critical enabler of the rapidly growing gene therapy and advanced biologics sector, driven by the increasing demand for specialized production capabilities and accelerated time-to-market for innovative therapies. The market is characterized by high technological barriers, requiring expertise in viral vector design, process development, cGMP-compliant manufacturing, and quality assurance. Companies in this space are leveraging advanced bioprocessing technologies, automation, and artificial intelligence tools to improve yield, consistency, and scalability while maintaining regulatory compliance. Strategic partnerships between biotechnology firms and CDMOs are becoming increasingly common, allowing developers to outsource complex manufacturing tasks and focus on clinical development and commercialization. Overall, the market is marked by intense competition among specialized service providers, rapid technological innovation, and growing adoption of viral vector-based therapies across diverse therapeutic areas, positioning CDMOs as indispensable partners in the biopharmaceutical value chain.
This report is a detailed and comprehensive analysis for global Viral Vector Manufacturing CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Viral Vector Manufacturing CDMO Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Viral Vector Manufacturing CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Viral Vector Manufacturing CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Viral Vector Manufacturing CDMO Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Viral Vector Manufacturing CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Viral Vector Manufacturing CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed）, Gene Universal, Polyplus (Sartorius), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Viral Vector Manufacturing CDMO Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adeno-associated Virus
Lentivirus
Adenovirus
HSV
Others
Market segment by Development Scope
Clinical stage CDMOs
Commercial stage CDMOs
End to end lifecycle CDMOs
Market segment by Manufacturing Technology
Adherent Cell Based
Suspension Based
Market segment by Application
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others
Market segment by players, this report covers
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
Exthera
Flash Therapeutics
VIVEBiotech
FinVector
uBriGene
Eurogentec
VGXI
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology
Hillgene
Asymchem
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Viral Vector Manufacturing CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Vector Manufacturing CDMO Services, with revenue, gross margin, and global market share of Viral Vector Manufacturing CDMO Services from 2021 to 2026.
Chapter 3, the Viral Vector Manufacturing CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Viral Vector Manufacturing CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Vector Manufacturing CDMO Services.
Chapter 13, to describe Viral Vector Manufacturing CDMO Services research findings and conclusion.

Buy now